OtherCommentary
A Strategic Guide to Improve and De-risk Vaccine Development: CEPI′s CMC Framework
Anna Särnefält, Ranna Eardley-Patel, Diletta Magini, Vishal Sonje, Antonio Guzzi, Renske Hesselink, Matthew Scotney, Alessandro Lazdins, Valerie Chambard, Christof Vinnemeier and Ingrid Kromann
PDA Journal of Pharmaceutical Science and Technology July 2024, pdajpst.2023.012912; DOI: https://doi.org/10.5731/pdajpst.2023.012912
Anna Särnefält
CEPI
Ranna Eardley-Patel
CEPI
Diletta Magini
CEPI
Vishal Sonje
CEPI
Antonio Guzzi
CEPI
Renske Hesselink
CEPI
Matthew Scotney
CEPI
Alessandro Lazdins
CEPI
Valerie Chambard
CEPI
Christof Vinnemeier
CEPI
Ingrid Kromann
CEPI
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 4
July/August 2024
A Strategic Guide to Improve and De-risk Vaccine Development: CEPI′s CMC Framework
Anna Särnefält, Ranna Eardley-Patel, Diletta Magini, Vishal Sonje, Antonio Guzzi, Renske Hesselink, Matthew Scotney, Alessandro Lazdins, Valerie Chambard, Christof Vinnemeier, Ingrid Kromann
PDA Journal of Pharmaceutical Science and Technology Jul 2024, pdajpst.2023.012912; DOI: 10.5731/pdajpst.2023.012912
A Strategic Guide to Improve and De-risk Vaccine Development: CEPI′s CMC Framework
Anna Särnefält, Ranna Eardley-Patel, Diletta Magini, Vishal Sonje, Antonio Guzzi, Renske Hesselink, Matthew Scotney, Alessandro Lazdins, Valerie Chambard, Christof Vinnemeier, Ingrid Kromann
PDA Journal of Pharmaceutical Science and Technology Jul 2024, pdajpst.2023.012912; DOI: 10.5731/pdajpst.2023.012912
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.